DB14131InvestigationalProtein Based Therapies
Basic Fibroblast Growth Factor (bFGF) is a single-chain polypeptide growth factor that plays a significant role in the process of wound healing and is a potent inducer of physiologic angiogenesis.... Several different forms of the human protein exist ranging from 18-24 kDa in size due to the use of alternative start sites within the fgf-2 gene.
- Primary indication
- Basic Fibroblast Growth Factor is not currently approved for any FDA or Health Canada approved indications.Curator reviewed
- Also known as
- Basic astrolial growth factor · Basic FGF · bFGF · FGF 2 · FGF-2
- Code names
- CCRIS 8682 · FCE 26184
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of September 26, 2025
Which companies are running trials of Basic Fibroblast Growth Factor, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account